Bernstein Starts Regeneron Pharma (REGN) at Outperform, 'Writing the next chapter of growth'
Tweet Send to a Friend
Bernstein analyst William Pickering initiates coverage on Regeneron Pharma (NASDAQ: REGN) with a Outperform rating and a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
